The importance of moderate hyperhomocysteinemia, and of other conventional risk factors such as age and sex, on the incidence of vascular pathologies are stressed in a recent case-controlled study conducted in nine European centers (Graham et al, 1997)
To inhibit glycolysis, 2-Deoxy-D-glucose (2-DG, Sigma D8375) or galactose (D-(+)-Galactose, Sigma G0750) was used at the indicated concentration
Approval status is use-specific and does not travel automatically to anti-aging or recovery claims
Christopher Gillis, MD, FRCSC, FAANS Dr
1 6-8 2 2-3 Romrawin Clinic 3 1-2 4 5 6
Zero adverse events across all groups No adverse events were reported in any of the three groups over the full 6-month treatment period